Thank you for your important research toward breakthroughs for people with Parkinson's and for your interest in working with The Michael J. Fox Foundation.
Below are MJFF’s open funding programs.
More information on our Application Guidelines can be found here, while information on proposal budgets and team composition can be found here in English and here in LATAM Spanish.
Email grants@michaeljfox.org with questions.
Browse Funding Opportunities
Open Programs
Open Programs
-
Personalized Approaches for Understanding, Assessing and Improving Gait in Parkinson’s Disease Research ProgramObjective:This program seeks to fund clinical testing on personalized approaches for understanding, assessing and improving gait in Parkinson’s disease (PD) to address the wide variances of gait challenges across the continuum of the disease. The program aims to establish standardized assessment and tailor treatments to individual symptoms that improves gait and motor-cognitive functions.Award Amount:$250,000 - $2,000,000Due Date:Pre-proposals Due: January 14, 2025
-
Parkinson's Disease Therapeutics Pipeline ProgramObjective:This program seeks to advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease (PD). The program is set up to benefit therapeutics with clear potential to prevent, stop, or delay disease progression or to reduce the burden of daily symptoms.Award Amount:Award amounts for this program may range from $250,000 for smaller, targeted programs to upwards of $2M for larger, multi-stage preclinical and/or clinical programsDue Date:Rolling Deadline
-
The Edmond J. Safra Fellowship in Movement DisordersObjective:The Edmond J. Safra Fellowship in Movement Disorders aims to grow the global base of movement disorder specialists — neurologists with additional training in Parkinson's disease and other movement disorders — by training movement disorder clinician-researchers who can provide expert care and lead scientific advances.Award Amount:$180,000 total to be used during the two-year fellowshipDue Date:December 5, 2024
Closed Programs
Closed Programs
-
Black and African American Connections to Parkinson's Disease (BLAAC PD)Objective:This program seeks to expand understanding of Parkinson’s disease within the Black and African American community and contribute to a more holistic, global understanding of the disease.Award Amount:Up to $90,000Due Date:July 27, 2023
-
Freezing of Gait (FOG) in Parkinson’s Disease Research ProgramObjective:This program supports clinical studies that advance the knowledge of Freezing of Gait (FOG) and balance disorders to support therapeutic treatments. Applications are open to multi-centric studies with cross-disciplinary teams.Award Amount:$250,000 to $2,000,000Due Date:September 26, 2023
-
Alpha-synuclein Post-translational Modification Quantification ProgramObjective:This program seeks to establish robust methods and tools that can quantify the amount and regional distribution of post-translational modifications of alpha-synuclein in Parkinson’s disease-relevant brain regions.Award Amount:Up to $1,000,000Due Date:Pre-Proposals Due: April 18, 2023
-
Lysosomal Biomarkers ProgramObjective:This program seeks to develop, optimize and validate biomarkers related to lysosomal function, protein clearance and lipid homeostasis.Award Amount:$350,000Due Date:January 17, 2023
-
Circuits & Cellular Targets for Parkinson’s Symptoms – Pre-clinical ProgramObjective:This program seeks to further our understanding of the pathophysiological mechanisms that contribute to Parkinson’s disease with pre-clinical models. It also aims to identify the specific links between brain regions, cell types and signaling pathways to behavioral endpoints related to motor and non-motor symptoms of Parkinson’s disease (PD).Award Amount:$250,000 - $500,000Due Date:September 27, 2022
-
Data-Driven Subtyping & Stratification ProgramObjective:This program supports efforts to identify and validate Parkinson’s disease (PD) subtypes using existing data. Outcomes should be leveraged toward improving biomarkers, therapeutic/clinical trial strategies and precision medicine.Award Amount:$50,000 to $375,000Due Date:September 27, 2022
-
Therapeutic Pipeline ProgramObjective:The Michael J. Fox Foundation funds work with potential for fundamentally altering disease course and/or significantly improving treatment of symptoms above and beyond current standards of care.Award Amount:Up to $500,000 (pre-clinical) or up to $2 million (clinical)Due Date:Funded Summer 2021
-
Target Advancement ProgramObjective:The Michael J. Fox Foundation funds work that leverages and translates basic research to enable therapeutic development.Award Amount:Up to $150,000 for 18 to 24 monthsDue Date:Funded Summer 2021
-
Translational Pipeline ProgramObjective:This program will support target validation, pre-clinical and clinical work to foster and accelerate the development of Parkinson’s therapeutics with potential for fundamentally altering disease course or significantly improving management of symptoms.Award Amount:$250,000 - $2 million (greater funding may be considered)Due Date:April 26, 2022
-
Development and Validation of Improved Outcome MeasuresObjective:This program funds work to develop objective biomarkers that can support therapeutic development in Parkinson’s.Award Amount:Up to $750,000 for up to two yearsDue Date:Funded Summer 2020
-
Biomarkers to Support Therapeutic Trials ProgramObjective:This program supports biomarkers research that will develop, optimize or analytically validate new or existing outcome measures to directly inform and transform therapeutic development.Award Amount:Up to $300,000Due Date:April 26, 2022
-
Analysis of Patient-Reported Outcomes from Fox InsightObjective:This program funds analyses of the patient-reported outcomes (PROs) and genetic data collected through the Fox Insight study.Award Amount:Up to $100,000 for one year grantsDue Date:Funded Summer 2021
-
Novel PET Tracer Development ProgramObjective:This program supports work to develop and validate PET imaging techniques utilizing radiotracers of a variety of disease-relevant targets that can ultimately be implemented in clinical practice and clinical trials.Award Amount:Up to $500,000Due Date:April 26, 2022
-
PIPETTE: 4R Tau and Alpha-Synuclein PET Tracer DevelopmentObjective:The PIPETTE Consortium (Philanthropic Investments in PET TracErs) is a funding partnership formed in 2017 by The Michael J. Fox Foundation and Rainwater Charitable Foundation (conveners of the Tau Consortium).Award Amount:Total funding available is $1 millionDue Date:Awarded Summer 2021
-
ASAP Collaborative Research Network: Circuitry and Brain-body InteractionsObjective:The ASAP Collaborative Research Network, a program of the Aligning Science Across Parkinson’s (ASAP) initiative being implemented through The Michael J. Fox Foundation, seeks to support multidisciplinary, multi-institutional research teams to address key knowledge gaps in the basic mechanisms that contribute to Parkinson’s development and progression.Award Amount:Up to $9 millionDue Date:Pre-proposals Due: December 2020
-
Investigating Environmental Factors that Increase the Risk for Parkinson’s DiseaseObjective:This funding program supported projects to investigate environmental exposures, such as chemicals or toxic emissions, that increase the risk of PD and/or influence disease progression.Award Amount:Up to $400,000 for up to two yearsDue Date:Awarded Spring 2021
-
Promoting Diversity, Equity and Inclusion in Parkinson’s Disease ResearchObjective:The Michael J. Fox Foundation seeks applications with the potential to increase knowledge about Parkinson’s disease in populations that have been excluded from or underrepresented in research.Award Amount:$50,000 up to $400,000 for 18 to 36 monthsDue Date:Pre-Proposals: April 2021
-
Alpha-synuclein Seed Amplification Assay ProgramObjective:This program supports research that will facilitate integration of alpha-synuclein seed amplification assays into clinical studies for the purposes of predicting prognosis, tracking disease progression and monitoring therapeutic response.Award Amount:$3M for Total ProgramDue Date:September 13, 2021
-
Therapeutic Pipeline Program: Pre-clinical StudiesObjective:This funding program — an Edmond J. Safra Core Program for PD Research — will support development of Parkinson’s disease (PD) therapeutics with potential for fundamentally altering disease course or significantly improving non-motor or motor symptoms.Award Amount:Up to $500,000Due Date:Pre-proposals Due: September 28, 2021
-
Parkinson’s Pathway BiomarkersObjective:The Michael J. Fox Foundation seeks applications with the potential to develop new/better biomarkers for measuring pathway function or dysfunction that can support therapeutic development for affected pathways in Parkinson’s disease (PD).Award Amount:Up to $300,000
-
Target Advancement: Tool Generation and Target ValidationObjective:This funding program — an Edmond J. Safra Core Program for PD Research — seeks to build conclusive evidence and develop field-enabling tools around early-stage biological targets in Parkinson’s disease (PD).Award Amount:Up to $200,000Due Date:Pre-proposals Due: September 28, 2021
-
Cellular Phenotyping in Human iPSCsObjective:This program will support phenotyping of human induced pluripotent stem cells (iPSCs) from our Parkinson’s Progression Markers Initiative (PPMI). Such work will facilitate future mechanistic studies and expedite drug screening and proof-of-concept testing for Parkinson’s therapeutics.Award Amount:Up to $200,000 (data analysis) or up to $1 million (phenotypic analysis)Due Date:September 28, 2021
-
Ken Griffin Alpha-synuclein Imaging CompetitionObjective:The Michael J. Fox Foundation has prioritized alpha-synuclein imaging as the most likely imaging approach to have an impact for therapeutic development. The goal of this $10-million funding program is to deliver a selective alpha-synuclein PET tracer for use in clinical studies.Award Amount:Initial $8.5M Total with Additional Future $1.5MDue Date:Awarded Summer 2020
-
Parkinson’s Pathway Molecular Data AnalysisObjective:This funding program will support high-impact projects that utilize existing data resources to increase molecular understanding of Parkinson’s disease (PD), correlate biological changes to clinical/other outcomes, and more deeply interrogate disrupted pathways in PD.Award Amount:Up to $350,000Due Date:Pre-proposals Due: September 28, 2021
-
MRI Biomarkers: Data Analysis and Tool GenerationObjective:This funding program will support studies to develop reproducible diagnostic, prognostic, and monitoring magnetic resonance imaging (MRI) biomarkers.Award Amount:$5M for Total ProgramDue Date:Pre-proposals Due: September 28, 2021
-
Grant Portal
View submitted or in progress applications.
-
Funding Alerts
Sign up for email updates on resources and initiatives to accelerate research and improve Parkinson's care.